[Protective effects of antioxidants against cardiovascular damage].
Ando
Katsuyuki
K
Health Service Center, University of Tokyo.
D053607:Adrenomedullin; D000804:Angiotensin II / Q000502:physiology; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control*; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D008019:Life Style; D008077:Lipoproteins, LDL / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D018384:Oxidative Stress; D010455:Peptides / Q000502:physiology / Q000627:therapeutic use; D017382:Reactive Oxygen Species; D011973:Receptors, LDL / Q000502:physiology; D051131:Receptors, Oxidized LDL; D051127:Scavenger Receptors, Class E; D013113:Spin Labels
D000975:Antioxidants; D003497:Cyclic N-Oxides; D008077:Lipoproteins, LDL; C495137:OLR1 protein, human; D010455:Peptides; D017382:Reactive Oxygen Species; D011973:Receptors, LDL; D051131:Receptors, Oxidized LDL; D051127:Scavenger Receptors, Class E; D013113:Spin Labels; C099252:oxidized low density lipoprotein; D000804:Angiotensin II; D053607:Adrenomedullin; D009569:Nitric Oxide; C001803:tempol